Development of NGS–Based Workflows for CQAs for Product Characterization in Cell and Gene Therapy

In this webinar, Andrew Hillhouse, Principal Scientist Group Lead at FUJIFILM Biotechnologies, explains how his team developed and validated NGS-based workflows to support product characterization for cell and gene therapies. You will learn how modular workflows spanning sample preparation, sequencing, bioinformatics, and reporting can be used to assess product integrity, genome integrity, and adventitious agents. Andrew also demonstrates how Genedata Selector Playbooks support the analysis and interpretation of complex sequencing datasets to enable robust characterization workflows. 

This talk is part of Genedata's Open Forum series on NGS-based workflows for biopharmaceutical R&D and manufacturing.